Novartis Türkiye Launches Digital Information Resource for FMF Disease

Novartis Turkey has taken an important digital step to raise public awareness about Familial Mediterranean Fever (FMF), one of the most common hereditary and chronic diseases seen worldwide in Turkey. The company has launched an Instagram account called "FMF'te Birlikte" (@fmftebirlikte) to enable FMF patients and their families to access reliable information.

FMF Is Most Common in Turkey Worldwide
FMF, known colloquially as "Mediterranean Fever," is described as a hereditary, chronic auto-inflammatory disease that is particularly prevalent in the Mediterranean region. According to epidemiological research, Turkey is the country where the disease is most frequently observed globally, making access to accurate information even more critical.

Scientific and Accessible Content About FMF
In medical literature, Familial Mediterranean Fever (FMF) is defined as a genetically inherited disease characterized by recurring fever attacks accompanied by abdominal, chest and joint pain. FMF typically begins in childhood and can be controlled through appropriate treatment and regular monitoring.

Through the @fmftebirlikte account it has launched, Novartis Turkey aims to create a reliable digital reference point based on scientific foundations. The account provides information in plain language that everyone can understand:

-Disease definition,

-Symptoms,

-Points to consider in daily life,

-Managing the treatment process,

-Common misconceptions,

-Frequently asked questions,

and other important information specific to FMF.

Digital Support for Patients and Families
In a statement, Novartis Turkey said, "We have launched the @fmftebirlikte page so that FMF patients and their families feel they are not alone on this journey and can access accurate information. We invite everyone in society to follow this digital platform for awareness."

To access the Instagram page: @fmftebirlikte